APA (7th ed.) Citation

S, T., S, G., S, C., PJ, P., A, K., I, P., . . . S, S. (2024). Impact of treat and extend criteria on proportions that can be extended after loading phase of 2 mg aflibercept therapy for neovascular age related macular degeneration: PRECISE Report 5. Eye (London, England), 38(14), 2737. https://doi.org/10.1038/s41433-024-03110-4

Chicago Style (17th ed.) Citation

S, Thottarath, et al. "Impact of Treat and Extend Criteria on Proportions That Can Be Extended After Loading Phase of 2 mg Aflibercept Therapy for Neovascular Age Related Macular Degeneration: PRECISE Report 5." Eye (London, England) 38, no. 14 (2024): 2737. https://doi.org/10.1038/s41433-024-03110-4.

MLA (9th ed.) Citation

S, Thottarath, et al. "Impact of Treat and Extend Criteria on Proportions That Can Be Extended After Loading Phase of 2 mg Aflibercept Therapy for Neovascular Age Related Macular Degeneration: PRECISE Report 5." Eye (London, England), vol. 38, no. 14, 2024, p. 2737, https://doi.org/10.1038/s41433-024-03110-4.